Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuangang Su

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 24, 2025
Farrerol alleviates microbiota dysbiosis-associated osteoporosis in IBD by inhibiting PI3K-AKT/MAPK signaling pathwaysNinglu Yin, Yuangang Su, Chaofeng Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2024
Hecogenin alleviates LPS-induced osteolysis via regulating pyroptosis and ROS involved Nrf2 activationZhijuan Liu, Yijie Gao, Xiaoliang Feng, et al.
Cell Death Discovery|March 30, 2026
Correction: Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathwaysKai Gan, Haoyu Lian, Tao Yang, et al.
International Journal of Molecular Medicine|April 13, 2023
Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathwaysFan Yang, Yuangang Su, Jiamin Liang, et al.
Frontiers in Pharmacology|September 16, 2022
Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα-NF-κB p65 ComplexJunchun Chen, Dezhi Song, Yang Xu, et al.
International Immunopharmacology|March 6, 2022
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signalingFeng Long, Runfeng Chen, Yuangang Su, et al.
Journal of Translational Medicine|November 23, 2023
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosisTao Yang, Weiwei Chen, Kai Gan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 1, 2023
Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in miceHui Wang, Dezhi Song, Linhua Wei, et al.
Pharmacological Research|August 21, 2022
Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathwayLinhua Wei, Weiwei Chen, Linke Huang, et al.
Cell Proliferation|August 8, 2023
IKK/NF-κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS-induced inflammatory osteolysisXiaoxiao Xie, Weiwei Chen, Minglian Xu, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 24, 2025
Farrerol alleviates microbiota dysbiosis-associated osteoporosis in IBD by inhibiting PI3K-AKT/MAPK signaling pathwaysNinglu Yin, Yuangang Su, Chaofeng Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2024
Hecogenin alleviates LPS-induced osteolysis via regulating pyroptosis and ROS involved Nrf2 activationZhijuan Liu, Yijie Gao, Xiaoliang Feng, et al.
Cell Death Discovery|March 30, 2026
Correction: Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathwaysKai Gan, Haoyu Lian, Tao Yang, et al.
International Journal of Molecular Medicine|April 13, 2023
Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathwaysFan Yang, Yuangang Su, Jiamin Liang, et al.
Frontiers in Pharmacology|September 16, 2022
Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα-NF-κB p65 ComplexJunchun Chen, Dezhi Song, Yang Xu, et al.
International Immunopharmacology|March 6, 2022
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signalingFeng Long, Runfeng Chen, Yuangang Su, et al.
Journal of Translational Medicine|November 23, 2023
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosisTao Yang, Weiwei Chen, Kai Gan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 1, 2023
Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in miceHui Wang, Dezhi Song, Linhua Wei, et al.
Pharmacological Research|August 21, 2022
Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathwayLinhua Wei, Weiwei Chen, Linke Huang, et al.
Cell Proliferation|August 8, 2023
IKK/NF-κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS-induced inflammatory osteolysisXiaoxiao Xie, Weiwei Chen, Minglian Xu, et al.
Pageof 5